CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo.
Mol Ther
; 25(8): 1782-1789, 2017 08 02.
Article
in En
| MEDLINE
| ID: mdl-28527722
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cells
/
HIV Infections
/
HIV-1
/
Gene Targeting
/
Receptors, CCR5
/
CRISPR-Cas Systems
Limits:
Animals
/
Humans
Language:
En
Journal:
Mol Ther
Journal subject:
BIOLOGIA MOLECULAR
/
TERAPEUTICA
Year:
2017
Document type:
Article
Affiliation country:
China
Country of publication:
United States